Internship

Strategic Finance Intern – 8-month Co-op/Internship

Posted on 11/16/2024

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Biotechnology
Healthcare

Compensation Overview

CA$19.04 - CA$21.35Hourly

Vancouver, BC, Canada

This is an on-site position based in Vancouver.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Data Analysis
Excel/Numbers/Sheets
Requirements
  • You are currently enrolled in a Bachelor's or Master's degree program in Finance, Accounting, Economics, Business Administration, or a related field
  • You have strong analytical skills with the ability to interpret financial and other data and draw actionable insights; prior co-op or internship experience in finance, consulting, or accounting would be considered an asset
  • You are proficient in Microsoft Excel and Google Sheets, and are looking forward to gaining exposure to other financial analysis tools such as SAP SAC and Monte Carlo simulations
  • You have excellent communication and interpersonal skills, with the ability to collaborate effectively across multidisciplinary teams
  • You are detail-oriented and highly organized, with the ability to manage multiple tasks and deadlines in a fast-paced environment.
  • You have a keen interest in the biotech and pharmaceutical industries, and are eager to apply your skills towards an impactful mission.
Responsibilities
  • Conducting independent research on various factors around drug development to support financial modeling
  • Contributing to resource allocation reviews for internal programs through supporting report generation, analysis, and collaborating with cross-functional teams to understand progress on programs and re-forecast investment requirements
  • Owning a number of processes during our quarterly close, and generating materials to support earnings call preparation
  • Assisting in the optimization of financial models and systems to enhance operations and strategic decision making

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Grant

Total Funding

$620.9M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

5%

1 year growth

0%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.

Help us improve and share your feedback! Did you find this helpful?